Logo image of LASR

NLIGHT INC (LASR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LASR - US65487K1007 - Common Stock

38.13 USD
-0.42 (-1.09%)
Last: 12/31/2025, 2:19:12 PM
Fundamental Rating

3

Taking everything into account, LASR scores 3 out of 10 in our fundamental rating. LASR was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of LASR is average, but there are quite some concerns on its profitability. LASR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

LASR had negative earnings in the past year.
In the past year LASR has reported a negative cash flow from operations.
LASR had negative earnings in each of the past 5 years.
In multiple years LASR reported negative operating cash flow during the last 5 years.
LASR Yearly Net Income VS EBIT VS OCF VS FCFLASR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -14.57%, LASR is not doing good in the industry: 68.55% of the companies in the same industry are doing better.
LASR has a worse Return On Equity (-19.92%) than 66.94% of its industry peers.
Industry RankSector Rank
ROA -14.57%
ROE -19.92%
ROIC N/A
ROA(3y)-17.55%
ROA(5y)-13.6%
ROE(3y)-21.54%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
LASR Yearly ROA, ROE, ROICLASR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

LASR's Gross Margin of 23.80% is on the low side compared to the rest of the industry. LASR is outperformed by 61.29% of its industry peers.
LASR's Gross Margin has declined in the last couple of years.
LASR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.55%
GM growth 5Y-10.9%
LASR Yearly Profit, Operating, Gross MarginsLASR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

6

2. Health

2.1 Basic Checks

LASR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LASR has more shares outstanding
The number of shares outstanding for LASR has been increased compared to 5 years ago.
There is no outstanding debt for LASR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LASR Yearly Shares OutstandingLASR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LASR Yearly Total Debt VS Total AssetsLASR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

LASR has an Altman-Z score of 14.09. This indicates that LASR is financially healthy and has little risk of bankruptcy at the moment.
LASR has a Altman-Z score of 14.09. This is amongst the best in the industry. LASR outperforms 91.13% of its industry peers.
LASR has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, LASR is in line with its industry, outperforming 54.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 14.09
ROIC/WACCN/A
WACC9.04%
LASR Yearly LT Debt VS Equity VS FCFLASR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

LASR has a Current Ratio of 5.63. This indicates that LASR is financially healthy and has no problem in meeting its short term obligations.
LASR has a Current ratio of 5.63. This is amongst the best in the industry. LASR outperforms 83.06% of its industry peers.
LASR has a Quick Ratio of 4.36. This indicates that LASR is financially healthy and has no problem in meeting its short term obligations.
LASR's Quick ratio of 4.36 is amongst the best of the industry. LASR outperforms 81.45% of its industry peers.
Industry RankSector Rank
Current Ratio 5.63
Quick Ratio 4.36
LASR Yearly Current Assets VS Current LiabilitesLASR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.33% over the past year.
Looking at the last year, LASR shows a quite strong growth in Revenue. The Revenue has grown by 12.05% in the last year.
The Revenue has been growing slightly by 2.37% on average over the past years.
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)12.05%
Revenue growth 3Y-9.75%
Revenue growth 5Y2.37%
Sales Q2Q%18.91%

3.2 Future

Based on estimates for the next years, LASR will show a very strong growth in Earnings Per Share. The EPS will grow by 38.38% on average per year.
LASR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.99% yearly.
EPS Next Y133.4%
EPS Next 2Y57.4%
EPS Next 3Y38.38%
EPS Next 5YN/A
Revenue Next Year29.09%
Revenue Next 2Y19.87%
Revenue Next 3Y16.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LASR Yearly Revenue VS EstimatesLASR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
LASR Yearly EPS VS EstimatesLASR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 -0.6

2

4. Valuation

4.1 Price/Earnings Ratio

LASR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 122.85, the valuation of LASR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LASR is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.35. LASR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 122.85
LASR Price Earnings VS Forward Price EarningsLASR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LASR Per share dataLASR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

LASR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LASR's earnings are expected to grow with 38.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.4%
EPS Next 3Y38.38%

0

5. Dividend

5.1 Amount

LASR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NLIGHT INC

NASDAQ:LASR (12/31/2025, 2:19:12 PM)

38.13

-0.42 (-1.09%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners85.97%
Inst Owner Change-0.2%
Ins Owners5.75%
Ins Owner Change3.54%
Market Cap1.94B
Revenue(TTM)227.53M
Net Income(TTM)-43.52M
Analysts83.08
Price Target42.69 (11.96%)
Short Float %5.88%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)246.62%
Min EPS beat(2)165.36%
Max EPS beat(2)327.89%
EPS beat(4)3
Avg EPS beat(4)130.83%
Min EPS beat(4)-48.92%
Max EPS beat(4)327.89%
EPS beat(8)7
Avg EPS beat(8)71.42%
EPS beat(12)9
Avg EPS beat(12)50.48%
EPS beat(16)11
Avg EPS beat(16)32.1%
Revenue beat(2)2
Avg Revenue beat(2)5.99%
Min Revenue beat(2)2.42%
Max Revenue beat(2)9.56%
Revenue beat(4)3
Avg Revenue beat(4)4.53%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)9.56%
Revenue beat(8)5
Avg Revenue beat(8)2.88%
Revenue beat(12)6
Avg Revenue beat(12)1.76%
Revenue beat(16)6
Avg Revenue beat(16)0.1%
PT rev (1m)0.86%
PT rev (3m)49.05%
EPS NQ rev (1m)-1.1%
EPS NQ rev (3m)3117.42%
EPS NY rev (1m)294.19%
EPS NY rev (3m)383.77%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)19.98%
Revenue NY rev (1m)6.27%
Revenue NY rev (3m)6.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 122.85
P/S 8.51
P/FCF N/A
P/OCF N/A
P/B 8.86
P/tB 9.42
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)0.31
Fwd EY0.81%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS4.48
BVpS4.3
TBVpS4.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.57%
ROE -19.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.8%
FCFM N/A
ROA(3y)-17.55%
ROA(5y)-13.6%
ROE(3y)-21.54%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.55%
GM growth 5Y-10.9%
F-Score4
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.05%
Cap/Sales 4.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.63
Quick Ratio 4.36
Altman-Z 14.09
F-Score4
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)72.24%
Cap/Depr(5y)107.55%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y133.4%
EPS Next 2Y57.4%
EPS Next 3Y38.38%
EPS Next 5YN/A
Revenue 1Y (TTM)12.05%
Revenue growth 3Y-9.75%
Revenue growth 5Y2.37%
Sales Q2Q%18.91%
Revenue Next Year29.09%
Revenue Next 2Y19.87%
Revenue Next 3Y16.99%
Revenue Next 5YN/A
EBIT growth 1Y21.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.81%
EBIT Next 3Y38.43%
EBIT Next 5YN/A
FCF growth 1Y-2699.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.77%
OCF growth 3YN/A
OCF growth 5YN/A

NLIGHT INC / LASR FAQ

What is the ChartMill fundamental rating of NLIGHT INC (LASR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to LASR.


What is the valuation status of NLIGHT INC (LASR) stock?

ChartMill assigns a valuation rating of 2 / 10 to NLIGHT INC (LASR). This can be considered as Overvalued.


How profitable is NLIGHT INC (LASR) stock?

NLIGHT INC (LASR) has a profitability rating of 0 / 10.


Can you provide the financial health for LASR stock?

The financial health rating of NLIGHT INC (LASR) is 6 / 10.